Category Innovation/ R&D

WHO Members To Act On Research Financing, Pandemic Preparedness

How to proceed with the results of an initiative aimed at finding real alternatives for innovative health research financing is on the agenda at next week's World Health Assembly (WHA). The assembly also is expected to approve the continuation of a working group on pandemic influenza preparedness.

Counterfeit Medicines In WTO Dispute Process, Heating Up At WHO

The international policy debate over counterfeit medicines and legitimate generics escalated today. Brazil and India took the first step in the World Trade Organization dispute settlement process for treatment of generics medicines falsely labelled counterfeit in Europe, and non-governmental organisations from both sides of the issue issued new releases stating their positions on the issues at the neighbouring World Health Organization.

New WHO Documents Show Results On IP, Innovation, Technology Transfer

Three new documents from the World Health Organization programme on intellectual property and innovation obtained by Intellectual Property Watch provide new evidence on how technology transfer is working, analyse research prioritisation at the WHO, and indicate progress on a monitoring and evaluation strategy for the programme's continued implementation, according to a preliminary reading.

US, WIPO Officials Assess Patent Reform, PCT, Copyright Priorities

NEW YORK - Republican and Democratic lawmakers in the United States are “hotlining” colleagues to ascertain if there is any objection to moving patent reform quickly through the US Senate, a representative of a major stakeholder in the debate said here Friday. Meanwhile, the US Copyright Office is working to get its priorities through a restructured Congress, and a World Intellectual Property Organization official warned of a possible divide in WIPO's norm-setting activities.

Biotech Convention Pays Homage To IP, Pledges To Increase Access To Medicine

Intellectual property rights and access to medicines were on the agenda at the first day of a biotechnology industry group’s annual convention yesterday. The group held a panel on IP rights and also released a policy statement on access to medicine in developing countries. The director of the US Patent and Trademark Office commented positively on the initiative.

Health Initiative Proposes Rewarding Innovation On Impact Results; Some See Hurdles

An alternative initiative to promote access to medicine with a method mimicking market mechanisms means to create additional incentives for health innovation, authors of the proposal said yesterday. But other health actors have reservations.

A public event was organised yesterday to discuss how the Health Impact Fund (HIF) could fit within existing structures and what challenges it could face.

Coordination Mechanism Adopted For WIPO Development Agenda Implementation

A mechanism to watch the continuing implementation of development-oriented principles into the World Intellectual Property Organization’s work has now been found. For many, the Development Agenda is the most important agreement in WIPO’s recent past, and the mechanism - which will monitor, assess and report on its implementation - was a critical area of importance in ensuring it reaches its full potential.

Global IP Enforcement Push Impacting Consumer Access, 2010 IP Watchlist Finds

The second edition of the Consumers International IP Watchlist has been published, with the conclusion that consumers are bearing collateral damage to the enforcement push by entertainment and media lobby groups encouraging stringent national legislations. Copyright laws and enforcement are changing, but mostly for the benefit of right holders, said the advocate group which encourages copyright exceptions.

《国家标准涉及专利的处置规则》最新稿：是不是向前一步？

2010年一月21日，中国标准化研究院1发布了《国家标准涉及专利的处置规则2（征求意见稿）》（简称《处置规则》)，向有利益关系的参与者征求意见。此《处置规则》为国家标准化管理委员会《涉及专利的国家标准制修订管理规定（暂行）（征求意见稿）》（简称《修订管理规定》)重要成分之一。3